United States · FDA National Drug Code directory

Divalproex Sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
70518-3055_571f402c-0293-040b-e063-6294a90ac649
Product NDC
70518-3055
Form
TABLET, DELAYED RELEASE
Composition / generic term
Divalproex Sodium
Labeler
REMEDYREPACK INC.
Marketing category
ANDA
Marketing start / end (source format)
20210323
Source listing expiry
20271231

Source-listed ingredients

  • DIVALPROEX SODIUM — 250 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 POUCH in 1 BOX (70518-3055-1) / 1 TABLET, DELAYED RELEASE in 1 POUCH (70518-3055-2) · 70518-3055-1
  • 100 POUCH in 1 BOX (70518-3055-3) / 1 TABLET, DELAYED RELEASE in 1 POUCH (70518-3055-4) · 70518-3055-3
  • 60 TABLET, DELAYED RELEASE in 1 BLISTER PACK (70518-3055-5) · 70518-3055-5
  • 30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (70518-3055-6) · 70518-3055-6
  • 30 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (70518-3055-7) · 70518-3055-7

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →